Save information for later
Sign Up

Learn About Gastrointestinal Stromal Tumor

What is the definition of Gastrointestinal Stromal Tumor?

A gastrointestinal stromal tumor (GIST) is a type of tumor that occurs in the gastrointestinal tract, most commonly in the stomach or small intestine. This type of tumor is thought to grow from specialized cells found in the gastrointestinal tract called interstitial cells of Cajal (ICCs) or precursors to these cells. Affected individuals can develop one or more tumors. GISTs are usually found in adults between ages 40 and 70; rarely, children and young adults develop this type of tumor.

What are the causes of Gastrointestinal Stromal Tumor?

Genetic changes in one of several genes are involved in the formation of GISTs. About 80 percent of cases are associated with a mutation in the KIT gene, and about 10 percent of cases are associated with a mutation in the PDGFRA gene. Mutations in the KIT and PDGFRA genes are associated with both familial and sporadic GISTs. Less than 10 percent of cases are SDH-deficient GISTs, which are associated with mutations or other changes in the SDHA, SDHB, SDHC, or SDHD gene. SDH-deficient GIST can be familial or sporadic. A small number of people with a GIST have mutations in other genes.

How prevalent is Gastrointestinal Stromal Tumor?

Approximately 5,000 new cases of GIST are diagnosed in the United States each year. SDH-deficient GIST accounts for about 5 to 7 percent of cases. However, GISTs may be more common than the estimate because small tumors may remain undiagnosed.

Is Gastrointestinal Stromal Tumor an inherited disorder?

Most cases of GIST are sporadic and are not inherited. These cases are associated with a somatic mutation, which is a genetic change that occurs only in the tumor cells and occurs during a person's lifetime.

Who are the top Gastrointestinal Stromal Tumor Local Doctors?
Hematology Oncology | Oncology
Hematology Oncology | Oncology

Oncology Associates Of Oregon P C

520 Country Club Pkwy, 
Eugene, OR 
 (0.8 mi)
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

James Butrynski is a Hematologist Oncology specialist and an Oncologist in Eugene, Oregon. Dr. Butrynski and is rated as an Advanced provider by MediFind in the treatment of Gastrointestinal Stromal Tumor. His top areas of expertise are Familial Colorectal Cancer, Adult Soft Tissue Sarcoma, Primary Lymphoma of the Brain, and Dehydration. Dr. Butrynski is currently accepting new patients.

Oncology | Hematology Oncology
Oncology | Hematology Oncology

Oncology Associates Of Oregon P C

520 Country Club Pkwy, 
Eugene, OR 
 (0.8 mi)
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Benjamin Cho is an Oncologist and a Hematologist Oncology provider in Eugene, Oregon. Dr. Cho and is rated as an Experienced provider by MediFind in the treatment of Gastrointestinal Stromal Tumor. His top areas of expertise are Paget Disease of the Breast, Breast Cancer, Marginal Zone Lymphoma (MZL), and Inflammatory Breast Cancer. Dr. Cho is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Oncology | Hematology Oncology
Oncology | Hematology Oncology
520 Country Club Pkwy, 
Eugene, OR 
 (0.8 mi)
Languages Spoken:
English, Italian
Accepting New Patients

Joseph Fiorillo is an Oncologist and a Hematologist Oncology provider in Eugene, Oregon. Dr. Fiorillo and is rated as an Experienced provider by MediFind in the treatment of Gastrointestinal Stromal Tumor. His top areas of expertise are Paget Disease of the Breast, Breast Cancer, Familial Colorectal Cancer, and Pleuropulmonary Blastoma. Dr. Fiorillo is currently accepting new patients.

What are the latest Gastrointestinal Stromal Tumor Clinical Trials?
The Correlation Between Ripretinib Exposure and the Efficacy and Safety in Patients with Advanced Gastrointestinal Stromal Tumors: an Observational Study

Summary: This is a prospective, single-center, observational study to explore the correlation between ripretinib exposure and the efficacy and safety in patients with advanced gastrointestinal stromal tumors

Match to trials
Find the right clinical trials for you in under a minute
Get started
Avapritinib in the Treatment of Unresectable or Recurrent Metastatic Gastrointestinal Stromal Tumors Non-exon18 Mutations of PDGFRA:A Real-world Study

Summary: This is a prospective, multicenter, observational real-world study to explore the Avapritinib therapy in GIST patients who definited Non-exon18 Mutations of PDGFRA.

Who are the sources who wrote this article ?

Published Date: July 14, 2021
Published By: National Institutes of Health